McKesson (NYSE:MCK) Stock Rating Upgraded by Wall Street Zen

Posted by Brian Himes on Oct 19th, 2026

McKesson (NYSE:MCK – Get Free Report) was upgraded by Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued on Saturday, Wall Street Zen reports.

Other equities research analysts also recently issued reports about the company. TD Cowen increased their price target on McKesson from $989.00 to $1,006.00 and gave the stock a “buy” rating in a report on Thursday, August 6th. Bank of America boosted their price objective on McKesson from $950.00 to $1,050.00 in a report on Thursday, August 6th. Citigroup upped their price objective on McKesson from $945.00 to $1,000.00 and gave the company a “buy” rating in a research report on Friday, July 24th. Argus upped their price objective on McKesson from $850.00 to $970.00 and gave the company a “buy” rating in a research report on Thursday, September 3rd. Finally, Leerink Partners increased their target price on McKesson from $1,030.00 to $1,070.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 7th. Fifteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, McKesson currently has a consensus rating of “Moderate Buy” and an average price target of $990.35.

View Our Latest Report on McKesson

McKesson Trading Up 0.1%

MCK stock opened at $1,005.39 on Friday. The stock has a market cap of $117.22 billion, a PE ratio of 26.90, a P/E/G ratio of 2.00 and a beta of 0.30. McKesson has a 12 month low of $723.68 and a 12 month high of $1,014.99. The company has a 50-day moving average price of $897.66 and a 200 day moving average price of $837.34.

McKesson (NYSE:MCK – Get Free Report) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $9.93 earnings per share for the quarter, topping analysts’ consensus estimates of $9.56 by $0.37. The company had revenue of $105.38 billion for the quarter, compared to analyst estimates of $103.88 billion. McKesson had a net margin of 1.12% and a negative return on equity of 253.21%. During the same period in the prior year, the company posted $8.26 EPS. The firm’s revenue for the quarter was up 7.7% on a year-over-year basis. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. Sell-side analysts forecast that McKesson will post 44.71 EPS for the current year.

Insider Transactions at McKesson

In other news, CAO B Jr sold 111 shares of the firm’s stock in a transaction that occurred on Tuesday, September 8th. The shares were sold at an average price of $891.45, for a total transaction of $98,950.95. Following the transaction, the chief accounting officer directly owned 521 shares of the company’s stock, valued at approximately $464,445.45. This trade represents a 17.56% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Bradley Lerman sold 301 shares of the business’s stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $892.33, for a total value of $268,591.33. The SEC filing for this sale provides additional information. 0.06% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On McKesson

A number of institutional investors and hedge funds have recently bought and sold shares of MCK. SteelPeak Wealth LLC grew its stake in McKesson by 382.3% in the 3rd quarter. SteelPeak Wealth LLC now owns 4,394 shares of the company’s stock valued at $3,755,000 after acquiring an additional 3,483 shares during the period. IFP Advisors Inc increased its holdings in McKesson by 10.7% in the 3rd quarter. IFP Advisors Inc now owns 7,514 shares of the company’s stock worth $6,416,000 after acquiring an additional 728 shares in the last quarter. Founders Grove Wealth Partners LLC increased its holdings in McKesson by 15.0% in the 3rd quarter. Founders Grove Wealth Partners LLC now owns 429 shares of the company’s stock worth $366,000 after acquiring an additional 56 shares in the last quarter. Robertson Stephens Wealth Management LLC increased its holdings in McKesson by 3.4% in the 3rd quarter. Robertson Stephens Wealth Management LLC now owns 678 shares of the company’s stock worth $580,000 after acquiring an additional 22 shares in the last quarter. Finally, Counterpoint Mutual Funds LLC raised its position in McKesson by 18.9% during the third quarter. Counterpoint Mutual Funds LLC now owns 11,235 shares of the company’s stock worth $9,593,000 after acquiring an additional 1,788 shares during the period. 85.07% of the stock is owned by institutional investors.

About McKesson

(Get Free Report)

McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and medical products to pharmacies, hospitals, health systems, physicians and other healthcare providers. The company also provides technology, data and business solutions designed to support prescription management, pharmacy operations and patient care.

McKesson’s principal activities include pharmaceutical distribution, medical-surgical supply distribution, specialty pharmaceutical services and oncology care support.